
Tao Synergies (NASDAQ: TAOX)
$5.99
(-5.4%)
-$0.34
Price as of August 1, 2025, 4:00 p.m. ET
Tao Synergies Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Tao Synergies Company Info
Synaptogenix, Inc. is a biopharmaceutical company, which engages in the development of Bryostatin and Platform Drug used for the treatment of Alzheimer’s disease, Fragile X Syndrome or Autism, Multiple Sclerosis, Parkinson’s Disease, Traumatic Brain Injury, and Stroke. The company was founded on October 31, 2012 and is headquartered in New York, NY.
News & Analysis
No articles found.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.